Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1775 of 3173 entries
View as:

The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00401245 Org: User:
Start: 12/31/06 End: 01/31/08 Due: 01/31/09

Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.

Phase: N/A Priority: Normal
NCT ID: NCT05560555 Org: User:
Start: 10/24/22 End: 11/15/22 Due: 11/15/23

A Study Of Oral Palbociclib (PD-0332991), A CDK4/6 Inhibitor, As Single Agent In Japanese Patients With Advanced Solid Tumors Or In Combination With Letrozole For The First-Line Treatment Of Postmenopausal Japanese Patients With ER (+) HER2 (-) Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01684215 Org: User:
Start: 10/19/12 End: 10/25/18 Due: 10/25/19

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Phase: N/A Priority: Normal
NCT ID: NCT00140036 Org: User:
Start: 09/30/02 End: 08/31/05 Due: 08/31/06

Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT02757625 Org: User:
Start: 07/20/16 End: 05/24/17 Due: 05/24/18

Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

Phase: N/A Priority: Normal
NCT ID: NCT01859949 Org: User:
Start: 10/31/02 End: 08/31/15 Due: 08/31/16

A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00073476 Org: User:
Start: 09/30/03 End: 02/28/05 Due: 02/28/06

Morphine-Sparing Effect And Safety Of Parecoxib Administered Intravenously For The Treatment Of Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT00143169 Org: User:
Start: 09/30/04 End: 06/30/05 Due: 06/30/06

A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations

Phase: N/A Priority: Normal
NCT ID: NCT05446142 Org: User:
Start: 07/01/22 End: 09/30/22 Due: 09/30/23

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01054222 Org: User:
Start: 05/31/10 End: 01/31/12 Due: 01/31/13

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00824655 Org: User:
Start: 03/31/09 End: 06/30/10 Due: 06/30/11

Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842.

Phase: N/A Priority: Normal
NCT ID: NCT03637790 Org: User:
Start: 09/13/18 End: 12/14/18 Due: 12/14/19

A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Phase: N/A Priority: Normal
NCT ID: NCT01302067 Org: User:
Start: 05/31/11 End: 11/30/12 Due: 11/30/13

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Phase: N/A Priority: Normal
NCT ID: NCT00836745 Org: User:
Start: 03/31/09 End: 07/31/12 Due: 07/31/13

Health Outcomes in Rheumatoid Arthritis in Greece

Phase: N/A Priority: Normal
NCT ID: NCT01001182 Org: User:
Start: 07/31/10 End: 06/30/12 Due: 06/30/13

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Phase: N/A Priority: Normal
NCT ID: NCT02890368 Org: User:
Start: 09/30/16 End: 03/31/20 Due: 03/31/21

A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05257798 Org: User:
Start: 02/28/22 End: 03/21/23 Due: 03/21/24

A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00471159 Org: User:
Start: 08/31/07 End: - Due: -

Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia

Phase: N/A Priority: Normal
NCT ID: NCT05116046 Org: User:
Start: 12/24/21 End: 03/30/23 Due: 03/30/24

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01272804 Org: User:
Start: 02/28/11 End: 07/31/11 Due: 07/31/12

Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)

Phase: N/A Priority: Normal
NCT ID: NCT04155541 Org: User:
Start: 01/24/20 End: 04/25/25 Due: 04/25/26

A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

Phase: N/A Priority: Normal
NCT ID: NCT05873751 Org: User:
Start: 04/24/23 End: 03/31/24 Due: 03/31/25

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00427895 Org: User:
Start: 02/27/07 End: 08/01/11 Due: 08/01/12

Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00073749 Org: User:
Start: 08/31/03 End: 12/31/10 Due: 12/31/11

Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV)

Phase: N/A Priority: Normal
NCT ID: NCT06067191 Org: User:
Start: 08/08/22 End: 12/02/22 Due: 12/02/23